Impact of Prior Malignancy on Survival Outcomes of Stage IV Pancreatic Adenocarcinoma: SEER-Based Cohort

被引:0
作者
Muneer J. Al-Husseini
Anas M. Saad
Tarek Turk
Mohamed A. Tabash
Omar Abdel-Rahman
机构
[1] Ain Shams University,Faculty of Medicine
[2] Damascus University,Faculty of Medicine
[3] Ain Shams University,Clinical Oncology Department, Faculty of Medicine
[4] University of Calgary and Tom Baker Cancer Center,Department of Oncology
来源
Journal of Gastrointestinal Cancer | 2019年 / 50卷
关键词
Survival outcomes; Pancreatic adenocarcinoma; SEER; Clinical trials;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:794 / 800
页数:6
相关论文
共 68 条
  • [1] Siegel RL(2016)Cancer statistics, 2016 CA Cancer J Clin 66 7-30
  • [2] Miller KD(2004)Epidemiology and prevention of pancreatic cancer Jpn J Clin Oncol 34 238-244
  • [3] Jemal A(2014)Pancreatic cancer: advances in treatment World Journal of Gastroenterology: WJG 20 9354-270
  • [4] Lowenfels AB(2006)Factors influencing inclusion of patients with malignancies in clinical trials Cancer 106 258-1240
  • [5] Maisonneuve P(2007)Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review JAMA 297 1233-1892
  • [6] Mohammed S(2000)Randomized, controlled trials, observational studies, and the hierarchy of research designs N Engl J Med 342 1887-16
  • [7] Van Buren GI(2002)Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med 137 10-1733
  • [8] Fisher WE(2001)Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment J Clin Oncol 19 1728-93
  • [9] Tournoux C(2005)External validity of randomised controlled trials:“to whom do the results of this trial apply?” Lancet 365 82-ee9
  • [10] Katsahian S(2016)Exclusion of gastrointestinal cancer patients with prior cancer from clinical trials: is this justified? Clin Colorectal Cancer 15 e53-184